Final

MassVentures

MassVentures Board Meeting

Published on September 2, 2022 at 7:47 AM EDT

Date and Time

Thursday September 8, 2022 at 8:00 AM EDT

Location

308 Congress Street (if in person)
Join Zoom Meeting

 

Meeting ID: 840-0424-4492
Password: 8792

 

Dial by your location
     (312) 626 6799 (Chicago)

 

Agenda

      Purpose Presenter Time
I. Opening Items 8:00 AM
  A. Call the Meeting to Order   Samantha Asker 1 m
  B. Examples of Mission   Charlie Hipwood 5 m
  C. Highlights Discuss Charlie Hipwood 1 m
II. Approvals 8:07 AM
  A. Board Minutes Approve Minutes Charlie Hipwood 1 m
    Approve minutes for MassVentures Board Meeting on July 28, 2022  
  B. Pre-investment action sheet - Talking Heads Wireless Vote Charlie Hipwood 1 m
  C. Amended Pre Investment Action Sheet - Harmony Baby Vote Charlie Hipwood 1 m
  D. Pre Investment Action Sheet - JetCool Vote Charlie Hipwood 1 m
  E. Comp Committee Minutes Approve Minutes Charlie Hipwood 1 m
III. Financial Matters 8:12 AM
  A. Treasurer's Report Discuss Jim Madison 5 m
  B. Approve Treasurer's Report Vote Charlie Hipwood 1 m
  C. Bank Signatory Confirmation Vote Charlie Hipwood 2 m
  D. Transfer of Restricted Funds Vote Jim Madison 4 m
IV. Executive Session 8:24 AM
  A. Roll Call Vote to Enter Executive Session Vote Charlie Hipwood 1 m
   
The Board of Directors will now go into Executive Session, pursuant to Chapter 30A, for the purpose of discussing the following:
   
1.  Regarding Investment matters:
  • Confidential financial information of applicants for MassVentures funds; and
  • Information regarding the competitive positions of such applicants in their  respective industries.
2.  Regarding Personnel / Compensation matters
  • Negotiation with nonunion personnel or conduct a collective bargaining session with a union in executive session, and may even agree on final contract terms.
The Board will reconvene in Open Session following Executive Session.
I will need a roll call vote from the members to go into Executive Session.
  
  B. Presentation - InGel Therapeutics Discuss Vinit Nijhawan 45 m
  C. Vote - InGel Therapeutics Vote Vinit Nijhawan 15 m
  D. Preview - ExtraSense Discuss Priya Yadav 15 m
  E. Preview - Brilliant Strings Discuss Stacy Swider 15 m
  F. Pipeline Report Discuss Priya Yadav 3 m
  G. Portfolio Update Discuss Charlie Hipwood 5 m
  H. Valuation Reports Discuss Charlie Hipwood 20 m
  I. Comp Committee Report Discuss Samantha Asker 10 m
  J. Vote to Approve the Comp Committee Recommendation Vote Samantha Asker 5 m
  K. Roll Call Vote to Return to Open Session Vote Charlie Hipwood 1 m
   
Having completed all business of this Executive Session, I will now ask the members to vote to reconvene in Open Session.

After Vote:

Anyone who was required to leave during Executive Session be invited back into the room.  We will now announce any Votes that took place during Executive Session.
  
V. Conflicts of Interest 10:39 AM
 
Board members are urged to review the Pipeline list of companies and disclose any potential or perceived conflict of interests.  This becomes important if a company becomes a prospective investment candidate, as the Committee member should exclude themselves from discussion or votes regarding the company.  New companies are listed in Red font.
 
  A. Conflicts Discuss Charlie Hipwood 5 m
VI. President's Report 10:44 AM
  A. General Update Discuss Charlie Hipwood 5 m
  B. MV Capital Update Discuss Charlie Hipwood 15 m
  C. MV Accelerate Update Discuss Charlie Hipwood 15 m
  D. Other Updates Discuss Charlie Hipwood 1 m
VII. Closing Items 11:20 AM
  A. Adjourn Meeting Vote